ARCHIVE

• Bungyo Rate Up 4.3 Points to 47.7% in 1st Half of FY2002
  January 13, 2003

• No More Room for Drug Marketing Deregulation: Mr Ishii of JPA
  January 13, 2003

• WORLD NEWS IN BRIEF
  January 13, 2003

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  January 13, 2003

• Sales of Novartis's Diovan Exceed \40 Billion
  January 13, 2003

• PRESS SEMINAR
  January 13, 2003

• Sankyo to Beef Up Marketing Force in Response to Mevalotin Patent Expiration
  January 13, 2003

• The 23rd General Meeting of the Japanese Society of Clinical Pharmaceutical and Therapeutics (2)
  January 13, 2003

• A New Horizon, A New Prospective
  January 6, 2003

• Korosho Reports Self-assessment of Its Own Policies
  January 6, 2003

• Learning from the Last Decade and Making Use of the Learning in the Next Decade
  January 6, 2003

• MEDICAL FACILITIES & NURSING CARE NEWS IN BRIEF
  January 6, 2003

• 2003: Integration to Disintegration
  January 6, 2003

• BULLETIN
  January 6, 2003

• Nippon Shinyaku Licenses Leukemia Drug from CTI Technologies of US
  January 6, 2003

• Headquarters for Drug, Medical Device Policy Holds 1st Meeting
  January 6, 2003

• Pharmacia, Yamanouchi File NDA for Celecoxib
  January 6, 2003

• REGULATORY NEWS IN BRIEF
  January 6, 2003

• Kyorin, Bayer Yakuhin to Comarket Baynas
  January 6, 2003

• BULLETIN
  January 6, 2003

ページ

• « 先頭
• ‹ Prev
• …
• 627
• 628
• 629
• 630
• 631
• 632
• 633
• 634
• 635
• …
• Next ›
• 最終 »